Clinical trial

Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now

NCT02835599

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2016-11-01

PhaseN/A

Study timeline

Study start (actual)2016-11-01Date precision: day

Registry last updated2017-08-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small-Cell Lung Cancerunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

ChicagoIllinois, United States1 DenverColorado, United States1 OmahaNebraska, United States1 RochesterMinnesota, United States1 TacomaWashington, United States1 Colorado SpringsColorado, United States1 JacksonMississippi, United States1 UrbanaIllinois, United States1 Santa RosaCalifornia, United States1 DuluthMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02835599 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.